Alveolar Soft Part Sarcoma research hub
4 indexed studies · 2 currently recruiting
- recruitingPHASE3
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
This study is looking at a new medicine called AL3818 (anlotinib) for people with advanced alveolar soft part sarcoma (ASPS). It aims to see how safe and effective it is. Currently, it's only for ASPS patients.
United States · China · Italy - active not recruitingPHASE1
MAGE-A4ᶜ¹º³²T for Multi-Tumor
This study is testing a new cell therapy for certain cancers that have a specific protein. It aims to see if it's safe and how well people tolerate it. The therapy uses your own modified cells to fight the cancer. Some participants will also receive a small amount of radiation.
United States · Canada - recruitingPHASE2
Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell Tumor
This study looks at a medicine called Pasireotide (Signifor) for two rare cancers, Desmoplastic Small Round Cell Tumor (DSRCT) and Synovial Sarcoma. It aims to see if Pasireotide can help keep the cancer from returning after initial intense treatments, potentially improving patient outcomes.
Germany - active not recruitingPHASE2
Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
This study looks at a new type of treatment called afamitresgene autoleucel for advanced synovial sarcoma or myxoid liposarcoma. It aims to see how well it works and if it's safe for people who have specific genetic markers.
United States · Canada · France